TITLE

Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease

AUTHOR(S)
Auffarth, B; Postma, D S; de Monchy, J G; van der Mark, T W; Boorsma, M; Koëter, G H
PUB. DATE
May 1991
SOURCE
Thorax;May1991, Vol. 46 Issue 5, p372
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66077234

 

Related Articles

  • Budesonide and fluticasone and adrenal suppression. Fouda, Mona A.; Al-Kassimi, Feisal A. // Annals of Thoracic Medicine;Oct-Dec2012, Vol. 7 Issue 4, p253 

    A letter to the editor is presented in response to the article "Comparison of the effect of high-dose inhaled budesonide and fluticasone on adrenal function in patients with severe chronic obstructive pulmonary disease," by A. Fahim and colleagues, in the October 2012 issue.

  • Cost effectiveness of budesonide/formoterol in a single inhaler for COPD compared with each monocomponent used alone. Löfdahl, Claes-Göran; Ericsson, Å; Svensson, Klas; Andreasson, Emma; Löfdahl, Claes-Göran; Ericsson, Asa // PharmacoEconomics;2005, Vol. 23 Issue 4, p365 

    Objective: To compare the healthcare costs and effects of budesonide/formoterol in a single inhaler with those of budesonide and formoterol monotherapies, and placebo, in a multinational study in patients with chronic obstructive pulmonary disease (COPD), National Heart, Lung and...

  • Making the Diagnosis of Asthma. McCormack, Meredith C.; Enright, Paul L. // Respiratory Care;May2008, Vol. 53 Issue 5, p583 

    Diagnostic tests can only increase or decrease the probability of the asthma diagnosis, so a thorough history is very important. In patients with asthma-like symptoms, spirometric evidence of airway obstruction plus a large bronchodilator response makes asthma much more likely. However, normal...

  • Pulmonary Function Tests and their Reversibility in Saudi Arabian Smokers. Parkhad, Suchitra; Palve, Sachin // National Journal of Physiology, Pharmacy & Pharmacology;2014, Vol. 4 Issue 1, p29 

    Background: Smoking is known as the major cause of chronic obstructive pulmonary disease (COPD). In COPD, most of pulmonary function tests (PFTs) those indicating the diameter of airways are reduced. There are reports that bronchodilator drugs have no or a very little effect on PFT of COPD...

  • Budesonide improves decreased airway conductance in infants with respiratory symptoms. A S Pelkonen // Archives of Disease in Childhood;Jul2009, Vol. 94 Issue 7, p536 

    OBJECTIVE: Inhaled corticosteroids (ICS) are commonly used to treat wheezing disorders in children, but few studies have investigated the effect of ICS on lung function in infants. We evaluated the efficacy of inhaled budesonide for decreased specific airway conductance (sGaw) as an indication...

  • Budesonide improves decreased airway conductance in infants with respiratory symptoms. Pelkonen, A. S.; Malmstr�m, K.; Malmberg, L. P.; Sarna, S.; Turpeinen, M.; Kajosaari, M.; Haahtela, T.; M�kel�, M. J. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Jul2009, Vol. 94 Issue 7, p22 

    Objective: Inhaled corticosteroids (ICS) are commonly used to treat wheezing disorders in children, but few studies have investigated the effect of ICS on lung function in infants. We evaluated the efficacy of inhaled budesonide for decreased specific airway conductance (sGaw) as an indication...

  • Does Inhaled Budesonide Produce Benefits in COPD? Walling, Anne D. // American Family Physician;11/1/1999, Vol. 60 Issue 7, p2156 

    Presents an evaluation on the treatment of chronic obstructive pulmonary disease (COPD) by inhaled corticosteroids. Long-term effects of inhaled budesonide in patients with COPD; Need for differentiation between asthma and COPD in patients with pulmonary symptoms.

  • Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study. Wan C Tan; William M Vollmer; Bernd Lamprecht; David M Mannino; Anamika Jithoo; Ewa Nizankowska-Mogilnicka; Filip Mejza; Thorarinn Gislason; Peter G J Burney; A Sonia Buist // Thorax;Aug2012, Vol. 67 Issue 8, p718 

    RationaleCriteria for a clinically significant bronchodilator response (BDR) are mainly based on studies in patients with obstructive lung diseases. Little is known about the BDR in healthy general populations, and even less about the worldwide patterns.Methods10 360 adults aged...

  • Chronic obstructive pulmonary disease and antibiotic use. Smith, Haley // South African Pharmaceutical Journal;2012, Vol. 79 Issue 5, p23 

    Chronic obstructive pulmonary disease (COPD) is a disease state resulting from an abnormal inflammatory response of the lungs to irritant particles and gases, with resultant progressive airflow limitation, that is partially reversible. It is associated with lung hyperinflation and systemic...

  • MicroRNA Expression Profiling in Mild Asthmatic Human Airways and Effect of Corticosteroid Therapy. Williams, Andrew E.; Larner-Svensson, Hanna; Perry, Mark M.; Campbell, Gaynor A.; Herrick, Sarah E.; Adcock, Ian M.; Erjefalt, Jonas S.; Kian Fan Chung; Lindsay, Mark A. // PLoS ONE;2009, Vol. 4 Issue 6, p1 

    Background: Asthma is a common disease characterised by reversible airflow obstruction, bronchial hyperresponsiveness and chronic inflammation, which is commonly treated using corticosteroids such as budesonide. MicroRNAs (miRNAs) are a recently identified family of non-protein encoding genes...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics